title: A new START for Sildenafil in pediatric pulmonary hypertension: reframing the dose-survival relationship in the STARTS-2 trial.
authors.affiliation: NYU School of Medicine, Departments of Pediatrics, Cardiothoracic Surgery, and Medicine, New York, NY.
authors.forename: Doff B
authors.initials: DB
authors.lastname: McElhinney
mesh_terms: D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines / Q000008:administration & dosage; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate
keywords: Editorials; United States Food and Drug Administration; heart diseases; hypertension, pulmonary; randomized controlled trial